A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

La investigación ha revelado que las mujeres que toman un tipo determinado de medicamentos son menos propensas a desarrollar esta enfermedad.